|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,578 ILa | +24.76% |
|
+14.79% | -36.10% |
| Mar. 31 | Panaxia Labs Israel Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 10 | Joseph Herman acquired 3.33% stake in Panaxia Labs Israel Ltd for ILS 1 million. | CI |
Panaxia Labs Israel Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was ILS 39.42 million compared to ILS 83.6 million a year ago. Net loss was ILS 43.27 million compared to ILS 21.38 million a year ago.
Basic loss per share from continuing operations was ILS 290 compared to ILS 150 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.10% | 3.76M | |
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +21.03% | 13.41B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B |
PANAXIA LABS ISRAEL LTD 
